BAXFEND

Serial Number 98779749
688

Registration Progress

Application Filed
Oct 1, 2024
Under Examination
Jan 6, 2026
Approved for Publication
Nov 11, 2025
Published for Opposition
Nov 11, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 06, 2026 174 days

Trademark Image

BAXFEND

Basic Information

Serial Number
98779749
Filing Date
October 1, 2024
Published for Opposition
November 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jan 6, 2026
Application
Pending
Classes
005

Rights Holder

AstraZeneca Ireland Limited

99
Address
College Business & Technology Park
Blanchardstown
Dublin 15 D15R925
IE

Ownership History

AstraZeneca Ireland Limited

Original Applicant
99
Dublin 15 IE

AstraZeneca Ireland Limited

Owner at Publication
99
Dublin 15 IE

Legal Representation

Attorney
Cara M. Kearney

USPTO Deadlines

Next Deadline
174 days remaining
NOA E-Mailed - SOU Required
Due Date
July 06, 2026
Extension Available
Until January 06, 2027

Application History

16 events
Date Code Type Description Documents
Jan 6, 2026 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 11, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 8, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 11, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 11, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Mar 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines

Classification

International Classes
005